These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28277032)

  • 1. Novel avenues for treating diabetic nephropathy: new investigational drugs.
    Lacava V; Pellicanò V; Ferrajolo C; Cernaro V; Visconti L; Conti G; Buemi M; Santoro D
    Expert Opin Investig Drugs; 2017 Apr; 26(4):445-462. PubMed ID: 28277032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic agents for the treatment of diabetic kidney disease.
    Hartman RE; Rao PSS; Churchwell MD; Lewis SJ
    Expert Opin Investig Drugs; 2020 Nov; 29(11):1277-1293. PubMed ID: 32799584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effective drugs for diabetic kidney disease? or not?
    Gentile G; Mastroluca D; Ruggenenti P; Remuzzi G
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):571-601. PubMed ID: 25376947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New potential agents in treating diabetic kidney disease: the fourth act.
    Williams ME
    Drugs; 2006; 66(18):2287-98. PubMed ID: 17181372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies.
    Warren AM; Knudsen ST; Cooper ME
    Expert Opin Ther Targets; 2019 Jul; 23(7):579-591. PubMed ID: 31154867
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging drugs for diabetic nephropathy.
    Bruno S; Cattaneo D; Perico N; Remuzzi G
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):747-71. PubMed ID: 16262561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents in development for the treatment of diabetic nephropathy.
    Fukami K; Cooper ME; Forbes JM
    Expert Opin Investig Drugs; 2005 Mar; 14(3):279-94. PubMed ID: 15833059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in drug discovery for diabetic kidney disease.
    Danta CC; Boa AN; Bhandari S; Sathyapalan T; Xu SZ
    Expert Opin Drug Discov; 2021 Apr; 16(4):447-461. PubMed ID: 33003971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel avenues for drug discovery in diabetic kidney disease.
    Breyer MD; Kretzler M
    Expert Opin Drug Discov; 2018 Jan; 13(1):65-74. PubMed ID: 29145743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for managing kidney disease in patients with diabetes.
    Thomas MC
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):55-70. PubMed ID: 23330907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on potential drugs for the treatment of diabetic kidney disease.
    Shepler B; Nash C; Smith C; Dimarco A; Petty J; Szewciw S
    Clin Ther; 2012 Jun; 34(6):1237-46. PubMed ID: 22578309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease.
    Santoro D; Pellicanò V; Visconti L; Trifirò G; Buemi M; Cernaro V
    Expert Opin Investig Drugs; 2015; 24(9):1199-218. PubMed ID: 26125126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.
    Patel DM; Bose M; Cooper ME
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational immunosuppressants in early-stage clinical trials for the treatment of multiple sclerosis.
    Gajofatto A; Turatti M
    Expert Opin Investig Drugs; 2018 Mar; 27(3):273-286. PubMed ID: 29455558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease.
    Swaminathan S; Shah SV
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):143-8. PubMed ID: 18277146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for the treatment of transplant rejection.
    Kihm LP; Zeier M; Morath C
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):683-95. PubMed ID: 22112166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic kidney disease: current and future targets.
    Kim MK
    Korean J Intern Med; 2017 Jul; 32(4):622-630. PubMed ID: 28704915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease.
    Anand K; Sabbagh M
    Expert Opin Investig Drugs; 2015; 24(10):1355-60. PubMed ID: 26289787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.